ArticleDiscover nano2026
Cationic carbon dot-silver nanohybrids with enhanced stability and redox control.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Silver nanoparticles (AgNPs) show promise for biomedical applications, but their functional stability remains a major challenge. Here, the photochemical synthesis of hybrid AgNPs using carbon dots (CDs) as both reducing and capping agents (CDs-AgNPs) is described, producing highly stable nanostructures under physiological conditions. Comparisons with traditionally synthesized AgNPs, using Irgacure-2959 photoreduction and sodium borohydride methods, indicate that CDs-AgNPs have better colloidal stability across a range of pH levels (4.5-8), ionic strengths (up to 500 mM in NaCl), and oxidative conditions, especially against peroxyl radicals for at least 2 h, whereas other AgNP formulations destabilize within minutes. Spectroscopic analysis confirmed the presence of CDs on the AgNP surface, forming a protective shell rich in amino groups. This shell prevents nanoparticle clumping and oxidation, while also enhancing antioxidant capacity compared to gallic acid and BHT standards, outperforming other standard AgNPs. In vitro cytotoxicity tests on cancerous and non-cancerous cell lines showed toxicity toward MCF cell lines at the highest concentration used, with CDs-AgNPs showing increased activity likely due to a pro-oxidant cellular mechanism. These findings demonstrate a green and reproducible method for creating carbon-silver nanohybrids with improved stability and redox control. This hybrid structure offers a platform to reduce instability and potential side effects associated with metallic nanomaterials, supporting their advancement in therapeutic applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.